Optic Nerve Diseases Epidemiology Forecast 2026-2035

Optic nerve diseases represent a growing global clinical concern, closely linked with neurodegenerative and ophthalmic conditions. According to the International Agency for the Prevention of Blindness (IAPB), glaucoma affected nearly 76 million individuals in 2020, projected to reach 112 million by 2040 globally. The optic nerve diseases epidemiology forecast highlights rising disease burden, notable demographic variations, and increasing focus on early diagnosis, targeted therapies, and integrated care strategies to improve long-term visual and neurological outcomes.

Optic Nerve Diseases Epidemiology Forecast Report Coverage

The analyst's “Optic Nerve Diseases Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of optic nerve diseases. It projects the future incidence and prevalence rates of optic nerve diseases cases across various populations. The study covers age, gender, and type as major determinants of the optic nerve diseases population. The report highlights patterns in the prevalence of optic nerve diseases over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of optic nerve diseases in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Optic Nerve Diseases Understanding: Disease Overview

Ocular optic nerve diseases involve damage or dysfunction of the optic nerve, leading to vision impairment or loss. Conditions include optic neuritis, glaucoma-related optic neuropathy, and ischemic optic neuropathy. Symptoms often include blurred vision, color vision defects, and visual field loss. Causes include autoimmune disorders, vascular insufficiency, and increased intraocular pressure. Early diagnosis is critical for preventing irreversible damage. Advances in imaging techniques and neuro-ophthalmology have improved detection and classification, supporting better outcomes in optic nerve disorders management, research, and clinical therapeutic development progress globally insights

Optic Nerve Diseases Epidemiology Perspective

The optic nerve diseases epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the optic nerve diseases epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for optic nerve diseases and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• As per Shiyi Shan et al., 2024, approximately 76 million individuals globally were affected by glaucoma in 2020, with projections indicating prevalent cases will reach 112 million by 2040, disproportionately affecting populations in Asia and Africa.
• According to Supriya B N et al., 2024, optic neuritis age-based distribution shows the highest prevalence in the 26-35 years age group at 36.6%, followed by 36-45 years at 32%, indicating greater disease burden among young to middle-aged adults.
• As per Nadia J. Abbass et al., 2025, females demonstrated 1.31 times higher odds of developing optic neuritis compared with males, reflecting consistent female predominance in US demyelinating optic nerve disease.
• As per Nadia J. Abbass et al., 2025, the highest US optic neuritis prevalence was observed in Black populations (57.8 per 100,000), followed by White populations (54.7 per 100,000), reflecting notable racial variation in disease burden.

Country-wise Optic Nerve Diseases Epidemiology

The optic nerve diseases epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Optic nerve diseases are supported by substantial epidemiological evidence from both the United States and the United Kingdom, reflecting diverse population-level trends. In the United States, Nadia J. Abbass et al. (2025) reported an optic neuritis prevalence of 51.6 per 100,000 in 2023, with higher burden among females and Black populations. In the United Kingdom, Braithwaite et al. (2020) observed a prevalence of 115 per 100,000 and an incidence of 3.7 per 100,000 person-years. These findings collectively contribute to a more comprehensive understanding of disease burden and healthcare planning.

Optic Nerve Diseases: Treatment Overview

Ocular optic nerve disease treatment focuses on preserving vision, reducing inflammation, and managing underlying causes. Therapies include corticosteroids for optic neuritis, intraocular pressure-lowering medications for glaucoma, and surgical interventions in advanced cases. Immunomodulatory agents may be used for autoimmune-related conditions. Neuroprotective strategies and rehabilitation support visual function recovery. Early intervention is essential to prevent irreversible optic nerve damage. Ongoing research is improving targeted therapies and outcomes, particularly through optic neuropathy treatment advancements and precision neuro-ophthalmology approaches, enhancing long-term visual prognosis and global clinical outcomes improvement strategies

Key Questions Answered

• What are the key findings of optic nerve diseases epidemiology in the 8 major markets?
• What will be the total number of patients with optic nerve diseases across the 8 major markets during the forecast period?
• What was the country-wise optic nerve diseases epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of optic nerve diseases patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of optic nerve diseases during the forecast period of 2026-2035?
• What are the currently available treatments for optic nerve diseases?
• What are the disease risks, signs, symptoms, and unmet needs of optic nerve diseases?

Scope of the Optic Nerve Diseases Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of optic nerve diseases based on several factors.
• Optic Nerve Diseases Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The optic nerve diseases report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.